Remedium Capital Partners, LLC quarter change: USA Other Stocks, Sold out
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, Remedium Capital Partners, LLC opened 0 positions, added to 0, reduced 0, sold out of 1 and left 1 unchanged. The largest increase in value was Damora Therapeutics Inc (+$225,003); the largest decrease was Crescent Biopharma Inc (-$6,636,163).
- Crescent Biopharma Inc: Country of operation United States; Class COM; Shares 2026-03-31 361,250; Shares 2026-06-30 0.
Two Form 13F-HR filings compared (SEC CIK 2104501): 2026-03-31 (filed 2026-05-19) and 2026-06-30 (filed 2026-08-07). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Iyo Bank, Ltd. | Japan | $0.281B | 35 |
| Biltmore Wealth Management, LLC | United States | $0.281B | 60 |
| INVESTMENT PARTNERS, LTD. | United States | $0.281B | 152 |
| Northern Right Capital Management, L.P. | United States | $0.281B | 25 |
| Bluesphere Advisors LLC | United States | $0.281B | 121 |
| Tiller Private Wealth, Inc. | United States | $0.281B | 66 |
| Financial Symmetry Inc | United States | $0.281B | 63 |
| Freedom Financial Partners LLC | United States | $0.281B | 88 |
| Monte Financial Group, LLC | United States | $0.282B | 100 |
| Owl Creek Wealth Partners LLC | United States | $0.281B | 1,239 |